Idź do Transakcji
Usługi finansowe | Opieka zdrowotna

SulAmérica and Rede D’Or São Luiz have announced a combination

SulAmérica (B3:SULA11), a leading insurance company in Brazil, has announced a combination with Rede D’Or São Luiz S.A. (B3:RDOR3), the largest Brazilian hospital network. The companies had a combined market value of approximately US$21 billion on 18 February 2022.

SulAmérica is one of the largest insurance companies in Brazil and operates in the health and dental insurance, life and pension plans, and asset management sectors. The company was founded in 1895 and is headquartered in Rio de Janeiro, Brazil.

Rede D’Or is the largest integrated healthcare network in Brazil, operating in the health sector, with an extensive network of private hospitals.

One of Oaklins’ teams in Brazil acted as the sole financial advisor to SulAmérica on its combination with Rede D’Or São Luiz S.A. The transaction will be submitted for approvals at shareholders’ meetings of both companies and to relevant regulatory agencies. Once the closing date is defined the companies will inform the market.

Porozmawiaj z zespołem obsługi transakcji

Richard Rainer

Partner Zarządzający
São Paulo, Brazylia
Oaklins Olimpia Partners

Irajá Guimarães

Partner
São Paulo, Brazylia
Oaklins Olimpia Partners

Sara Rezende

Partner
São Paulo, Brazylia
Oaklins Olimpia Partners

Powiązane transakcje

Rare Patient Voice has been acquired by Konovo
Opieka zdrowotna | TMT

Rare Patient Voice has been acquired by Konovo

Rare Patient Voice has been acquired by Konovo, a technology-first healthcare intelligence company backed by Fraser Healthcare Partners.

Więcej informacji
Lindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland
Opieka zdrowotna

Lindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland

LabPoint Medical Laboratories AG has been acquired by Affidea Switzerland AG. Through the transaction, Lindenhofgruppe AG gains a strong strategic partner to support the further development of LabPoint and will remain a shareholder with a reduced stake, continuing as a key customer of the company. It lays the foundation for LabPoint’s sustainable development under a new anchor shareholder, with the aim of further strengthening and selectively expanding its position in laboratory diagnostics.

Więcej informacji
Smart Capital has finalized a rights issue
Usługi finansowe

Smart Capital has finalized a rights issue

Smart Capital S.p.A. has finalized a rights issue to continue executing its growth plan and increase its investment capacity. The fundraising supports the expansion of its investment portfolio and the strengthening of its positions in higher-quality investee companies with stronger growth prospects.

Więcej informacji